Deutsch English Français

Contact

EP2136789

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2136789

EP2136789 - SOLID DOSAGE FORMS COMPRISING ALISKIREN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 09.10.2015 Database last updated on 13.07.2024
Most recent event Tooltip	09.10.2015	Application deemed to be withdrawn	published on 11.11.2015 [2015/46]
Applicant(s)	For all designated states KRKA, tovarna zdravil, d.d., Novo mesto Smarjeska cesta 6 8501 Novo mesto / SI
	[N/P]
Former [2010/01]	For all designated states Krka, Torvarna Zdravil, D.D., Novo Mesto Smarjeska cesta 6 8501 Novo mesto / SI
Inventor(s)	01 / VRECER, Franc Potok 5b 8351 Straza pri Novem mestu / SI
	02 / SKRABANJA, Vida Zupnca 4b 8000 Novo mesto / SI
	03 / ZAJC, Natalija Svibnik 23 8340-Crnomelj / SI
	04 / GOJAK, Urska Kotnikova 29 1000 Ljubljana / SI
	[2010/01]
Representative(s)	Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB Beselerstrasse 4 22607 Hamburg / DE
	[N/P]
Former [2010/01]	UEXKÜLL & STOLBERG Patentanwälte Beselerstrasse 4 22607 Hamburg / DE
Former [2009/51]	UEXKÜLL & STOLBERG Patentanwälte Beselerstrasse 4 22607 Hamburg / DE
Application number, filing date	08734694.6	20.03.2008
	[2010/01]
	WO2008EP02257
Priority number, date	EP20070006055	23.03.2007 Original published format: EP 07006055
	[2010/01]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2008116601
	Date:	02.10.2008
	Language:	EN
	[2008/40]
	Type:	A2 Application without search report
	No.:	EP2136789
	Date:	30.12.2009
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 02.10.2008 takes the place of the publication of the European patent application.
	[2009/53]
Search report(s)	International search report - published on:	EP	23.07.2009
Classification	IPC:	A61K9/16, A61K9/20, A61K31/165	[2010/01]
	CPC:	A61K31/165 (EP,US); A61P29/00 (EP); A61P3/10 (EP); A61P9/00 (EP); A61P9/02 (EP); A61P9/04 (EP); (+) A61P9/10 (EP); A61P9/12 (EP) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/01]
Extension states	AL	05.10.2009
	BA	05.10.2009
	RS	05.10.2009
Title	German:	FESTE DOSIERUNGSFORMEN MIT ALISKIREN UND PHARMAZEUTISCH AKZEPTABLEN SALZEN DAVON	[2010/01]
	English:	SOLID DOSAGE FORMS COMPRISING ALISKIREN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF	[2010/01]
	French:	FORMES DE DOSAGE SOLIDE COMPORTANT DE L'ALISKIREN ET SES SELS PHARMACEUTIQUES ACCEPTABLES	[2010/01]
Entry into regional phase	05.10.2009	National basic fee paid
	05.10.2009	Designation fee(s) paid
	05.10.2009	Examination fee paid
Examination procedure	05.10.2009	Amendment by applicant (claims and/or description)
	05.10.2009	Examination requested [2009/53]
	27.01.2015	Despatch of a communication from the examining division (Time limit: M04)
	09.06.2015	Application deemed to be withdrawn, date of legal effect [2015/46]
	03.07.2015	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/46]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 27.01.2015
Fees paid	Renewal fee
	15.03.2010	Renewal fee patent year 03
	15.03.2011	Renewal fee patent year 04
	14.03.2012	Renewal fee patent year 05
	11.03.2013	Renewal fee patent year 06
	12.03.2014	Renewal fee patent year 07
	Penalty fee
	Additional fee for renewal fee
	31.03.2015	08 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XY]US2006018960 (RIGASSI-DIETRICH PETRA G [CH], et al) [X] 1-4,12,18,19 * page 1, paragraphs 2,3,5,7-10,13 * * page 2, paragraphs 22,24-35 * * page 3, paragraphs 36-52 * * page 4, paragraphs 53-62,66-68 * * page 5, paragraphs 78-91,98,99 * * page 6, paragraphs 100-102 * * page 7 - page 8 * [Y] 1,5,13-17;
		[XY]US2005272790 (RIGASSI-DIETRICH PETRA G [CH], et al) [X] 1-4,12,18,19 * page 1, paragraphs 2,3,5-10,13 * * page 2, paragraphs 25-37 * * page 3, paragraphs 38-47 * * page 4, paragraphs 56-75 * * page 5, paragraphs 76-92,95-102 * * page 6, paragraphs 103-106 * * page 9 - page 10 * [Y] 1,5,13-17;
		[Y]EP0678503 (CIBA GEIGY AG [CH]) [Y] 1 * the whole document *;
		[Y]WO2006041974 (NOVARTIS AG [CH], et al) [Y] 1-3,9,11 * paragraphs [0002] - [0007] * * page 11, paragraphs 2,4 * * page 12, paragraph 2 * * page 20 - page 28 *;
		[Y]WO03097098 (NOVARTIS AG [CH], et al) [Y] 1-3,9,11 * the whole document *;
		[Y]US2005182042 (FELDMAN DAVID L [US], et al) [Y] 1-3,9,11 * the whole document *;
		[Y]WO2006116435 (NOVARTIS AG [CH], et al) [Y] 1-3,9,11 * page 9, paragraphs 3,4 * * page 10 - page 15 * * page 21 - page 23 *;
		[Y]WO2005116016 (IRM LLC [US], et al) [Y] 1-3,10 * page 9, paragraph 36 * * page 10, paragraphs 39,40 * * page 11, paragraphs 41-47 *;
		[Y]WO2006029349 (NOVARTIS AG [CH], et al) [Y] 1-3,10 * page 1, paragraph 1 * * page 21 - page 29 *;
		[AP]EP1782859 (NOVO NORDISK AS [DK]) [AP] 1-17,19 * the whole document *
		[Y] - VILLAMIL, A. ET AL, "Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide", J. HYPERTENS., (200701), vol. 25, pages 217 - 226, XP002435254 [Y] 1,9,11 * the whole document * DOI: http://dx.doi.org/10.1097/HJH.0b013e3280103a6b
	Examination	- ROYCE A ET AL, "ALTERNATIVE GRANULATION TECHNIQUE: MELT GRANULATION", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, NEW YORK, NY, US, (19960101), vol. 22, no. 9/10, doi:10.3109/03639049609065921, ISSN 0363-9045, pages 917 - 924, XP009059037 DOI: http://dx.doi.org/10.3109/03639049609065921
		- P Heng ET AL, "Melt Processes for Oral Solid Dosage Forms", Encyclpedia of Pharmaceutical Technology Third Edition Volume 4, informa Healthcare, (20070102), pages 2257 - 2261, ISBN 978-0-84-939393-8, XP055073802

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p